BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6102031)

  • 21. Distribution of all-trans-retinoic acid in normal and vitamin A deficient mice: correlation to retinoic acid receptors in different tissues of normal mice.
    Zhuang YH; Sainio EL; Sainio P; Vedeckis WV; Ylikomi T; Tuohimaa P
    Gen Comp Endocrinol; 1995 Nov; 100(2):170-8. PubMed ID: 8582598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pharmacokinetics of all-trans-retinoic acid and N-(2-hydroxyethyl)retinamide in mice as determined with a sensitive and convenient procedure. Solid-phase extraction and reverse-phase high performance liquid chromatography.
    McPhillips DM; Kalin JR; Hill DL
    Drug Metab Dispos; 1987; 15(2):207-11. PubMed ID: 2882980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of all-trans retinoic acid, 13-cis retinoic acid, and fenretinide in plasma and brain of Rat.
    Le Doze F; Debruyne D; Albessard F; Barre L; Defer GL
    Drug Metab Dispos; 2000 Feb; 28(2):205-8. PubMed ID: 10640519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic and metabolism studies of two novel 1-deaza-7,8-dihydropteridines in mice.
    Noker PE; Hill DL; Kalin JR; Temple CG; Montgomery JA
    Drug Metab Dispos; 1985; 13(6):677-81. PubMed ID: 2867870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid.
    Nau H
    J Am Acad Dermatol; 2001 Nov; 45(5):S183-7. PubMed ID: 11606951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice.
    Achkar CC; Bentel JM; Boylan JF; Scher HI; Gudas LJ; Miller WH
    Drug Metab Dispos; 1994; 22(3):451-8. PubMed ID: 8070324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. All-trans-retinoic acid in maternal plasma and teratogenicity in rats and rabbits.
    Tembe EA; Honeywell R; Buss NE; Renwick AG
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):456-72. PubMed ID: 8975771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism of oral 9-cis-retinoic acid in the human. Identification of 9-cis-retinoyl-beta-glucuronide and 9-cis-4-oxo-retinoyl-beta-glucuronide as urinary metabolites.
    Sass JO; Masgrau E; Saurat JH; Nau H
    Drug Metab Dispos; 1995 Sep; 23(9):887-91. PubMed ID: 8565776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of phenobarbital, 3-methylcholanthrene, and retinoid pretreatment on disposition of orally administered retinoids in mice.
    Kalin JR; Wells MJ; Hill DL
    Drug Metab Dispos; 1984; 12(1):63-7. PubMed ID: 6141914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incorporation of all-trans retinoic acid into lipoplexes inhibits nuclear factor kappaB activation mediated liver injury induced by lipoplexes in mice.
    Charoensit P; Kawakami S; Higuchi Y; Hashida M
    J Gene Med; 2008 Jan; 10(1):61-9. PubMed ID: 18001002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biosynthesis of 9-cis-retinoic acid from 9-cis-beta-carotene in human intestinal mucosa in vitro.
    Wang XD; Krinsky NI; Benotti PN; Russell RM
    Arch Biochem Biophys; 1994 Aug; 313(1):150-5. PubMed ID: 8053676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disposition of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-phosphate in mice and dogs.
    Noker PE; Duncan GF; El Dareer SM; Hill DL
    Cancer Treat Rep; 1983 May; 67(5):445-56. PubMed ID: 6189605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enzymatic hydrolysis of retinamides.
    Shih TW; Shealy YF; Hill DL
    Drug Metab Dispos; 1988; 16(3):337-40. PubMed ID: 2900722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The area under the concentration-time curve of all-trans-retinoic acid is the most suitable pharmacokinetic correlate to the embryotoxicity of this retinoid in the rat.
    Tzimas G; Thiel R; Chahoud I; Nau H
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):436-44. PubMed ID: 9144460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of a novel retinoic acid metabolism inhibitor, 4-(1H-imidazol-1-yl)retinoic acid (VN/14-1RA) and other retinoids in rat plasma by liquid chromatography with diode-array detection.
    Wu C; Njar V; Brodie A; Borenstein M; Nnane I
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(2):203-8. PubMed ID: 15380716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Method to determine 4-oxo-retinoic acids, retinoic acids and retinol in serum and cell extracts by liquid chromatography/diode-array detection atmospheric pressure chemical ionisation tandem mass spectrometry.
    Rühl R
    Rapid Commun Mass Spectrom; 2006; 20(16):2497-504. PubMed ID: 16862622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of liver metastasis by all-trans retinoic acid incorporated into O/W emulsions in mice.
    Chansri N; Kawakami S; Yamashita F; Hashida M
    Int J Pharm; 2006 Sep; 321(1-2):42-9. PubMed ID: 16790329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cis-trans interconversion of acitretin in man.
    Geiger JM; Brindley CJ
    Skin Pharmacol; 1988; 1(4):230-6. PubMed ID: 2978787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of all-trans-, 13-cis- and 9-cis-retinoic acid to whole rat embryos and maternal serum following oral administration of a teratogenic dose of all-trans-retinoic acid.
    Ward SJ; Morriss-Kay GM
    Pharmacol Toxicol; 1995 Mar; 76(3):196-201. PubMed ID: 7617545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.